Shanghai Inotech Biotechnology
Synthetic biology company focused on research and production of green biological products
About Shanghai Inotech Biotechnology
Enlogics is a synthetic biology company dedicated to the research and production of environmentally friendly biological products. The company operates in the synthetic biology market, aiming to set industry standards for quality and pricing. Enlogics serves clients interested in sustainable and green solutions, leveraging its expertise in synthetic biology to develop products that meet these demands. The business model revolves around continuous innovation and development, with a focus on creating products that are both effective and eco-friendly. Revenue is generated through the sale of these green biological products, targeting industries that prioritize sustainability. Founded by Mr. Chu Xiaohe, who has extensive experience in synthetic biology technologies, Enlogics is committed to advancing the field and maintaining a competitive edge in the market.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 20.0/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Mar 2025 | $21M | $83M | Feitu Venture Capital · Jiangsu Hengxing New Material Technology · Hongsheng Capital · Hefei Industry Investment Group | ↗ |
| SPINOUT✓Other financing | Sep 2022 | $0 | — | Zhejiang University of Technology | — |
Growth signals
Latest recorded traffic for Shanghai Inotech Biotechnology is 360 monthly website visits, down 53.2% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Inotech Biotechnology in its local ecosystem
The Shanghai Inotech Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- HCHongsheng Capital
Zhang Jianghaoheng- FCFeitu Venture Capital
- JTJiangsu Hengxing New Material Technology
- HGHefei Industry Investment Group
Other known investors1 additional known investor
Zhejiang University of Technology
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Inotech Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Inotech Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









